Nonadherence with INR monitoring and anticoagulant complications

Thrombosis Research

Volumn 132, Issue 2, 2013, Pages

  Witt, Daniel M ^a,b   Delate, Thomas ^a,b   Clark, Nathan P ^a,b   Garcia, David A ^c   Hylek, Elaine M ^d   Ageno, Walter ^e   Dentali, Francesco ^e   Crowther, Mark A ^f  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF INSUBRIA   (Italy)

^f MCMASTER UNIVERSITY   (Canada)

Author keywords

Adherence; Adverse; Anticoagulants; Assessment; Drug; Event; International; Medication; Normalized; Outcome; Ratio; Warfarin

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; AGED; BLEEDING; COHORT ANALYSIS; CONFERENCE PAPER; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VENOUS THROMBOEMBOLISM;

ADVERSE DRUG EVENT; ANTICOAGULANTS; CDS; CHRONIC DISEASE SCORE; CI; CLINICAL PHARMACY ANTICOAGULATION SERVICE; CONFIDENCE INTERVAL; CPAS; DEEP VEIN THROMBOSIS; DVT; HAZARD RATIO; HR; ICD-9; INR; INTERNATIONAL CLASSIFICATION OF DISEASES, 9TH REVISION; INTERNATIONAL NORMALIZED RATIO; KAISER FOUNDATION HEALTH PLAN; KAISER PERMANENTE COLORADO; KFHP; KPCO; LMWH; LOW-MOLECULAR-WEIGHT HEPARIN; MEDICATION ADHERENCE; OUTCOME ASSESSMENT; PE; PULMONARY EMBOLISM; TIME IN THERAPEUTIC INR RANGE; TTR; WARFARIN;

AGED; ANTICOAGULANTS; COHORT STUDIES; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; LONGITUDINAL STUDIES; MALE; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WARFARIN;

EID: 84883770901     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.06.006     Document Type: Conference Paper

References (23)

1. W. Ageno, A.S. Gallus, A. Wittkowsky, M. Crowther, E.M. Hylek, and G. Palareti Oral Anticoagulant Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e44S e88S
2. D.S. Budnitz, N. Shehab, S.R. Kegler, and C.L. Richards Medication use leading to emergency department visits for adverse drug events in older adults Ann Intern Med 147 2007 755 765
3. L. Osterberg, and T. Blaschke Adherence to medication N Engl J Med 353 2005 487 497
4. N.J. Davis, H.H. Billett, H.W. Cohen, and J.H. Arnsten Impact of adherence, knowledge, and quality of life on anticoagulation control Ann Pharmacother 39 2005 632 636
5. C.S. Parker, Z. Chen, M. Price, R. Gross, J.P. Metlay, and J.D. Christie Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE study J Gen Intern Med 22 2007 1254 1259
6. I.A. Orensky, and D.A. Holdford Predictors of noncompliance with warfarin therapy in an outpatient anticoagulation clinic Pharmacotherapy 25 2005 1801 1808
7. A.B. Platt, A.R. Localio, C.M. Brensinger, D.G. Cruess, J.D. Christie, and R. Gross Risk factors for nonadherence to warfarin: results from the IN-RANGE study Pharmacoepidemiol Drug Saf 17 2008 853 860
8. A.B. Platt, A.R. Localio, C.M. Brensinger, D.G. Cruess, J.D. Christie, and R. Gross Can We Predict Daily Adherence to Warfarin? Results from the IN-RANGE Study Chest 137 2010 883 889
9. D.G. Cruess, A.R. Localio, A.B. Platt, C.M. Brensinger, J.D. Christie, and R. Gross Patient Attitudinal and Behavioral Factors Associated with Warfarin Non-adherence at Outpatient Anticoagulation Clinics Int J Behav Med 17 2010 33 42
10. D.M. Witt, M.A. Sadler, R.L. Shanahan, G. Mazzoli, and D.J. Tillman Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy Chest 127 2005 1515 1522
11. D.J. Tillman, S.L. Charland, and D.M. Witt Effectiveness and economic impact associated with a program for outpatient management of acute deep vein thrombosis in a group model health maintenance organization Arch Intern Med 160 2000 2926 2932
12. C.A. Naranjo, U. Busto, E.M. Sellers, P. Sandor, I. Ruiz, and E.A. Roberts A method for estimating the probability of adverse drug reactions Clin Pharmacol Ther 30 1981 239 245
13. D.O. Clark, K.M. Von, K. Saunders, W.M. Baluch, and G.E. Simon A chronic disease score with empirically derived weights Med Care 33 1995 783 795
14. K.M. Von, E.H. Wagner, and K. Saunders A chronic disease score from automated pharmacy data J Clin Epidemiol 45 1992 197 203
15. R. Bauersachs, S.D. Berkowitz, B. Brenner, H.R. Buller, H. Decousus, and A.S. Gallus Oral rivaroxaban for symptomatic venous thromboembolism N Engl J Med 363 2010 2499 2510
16. H.R. Buller, M.H. Prins, A.W. Lensin, H. Decousus, B.F. Jacobson, and E. Minar Oral rivaroxaban for the treatment of symptomatic pulmonary embolism N Engl J Med 366 2012 1287 1297
17. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, and A. Parekh Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
18. C.B. Granger, J.H. Alexander, J.J. McMurray, R.D. Lopes, E.M. Hylek, and M. Hanna Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
19. M.R. Patel, K.W. Mahaffey, J. Garg, G. Pan, D.E. Singer, and W. Hacke Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
20. J. Raunso, C. Selmer, J.B. Olesen, M.G. Charlot, A.M. Olsen, and D.M. Bretler Increased short-term risk of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillation Eur Heart J 33 2012 1886 1892
21. R.A. Rodriguez, M. Carrier, and P.S. Wells Non-adherence to new oral anticoagulants: a reason for concern during long-term anticoagulation? J Thromb Haemost 11 2013 390 394
22. F.R. Rosendaal, S.C. Cannegieter, F.J. van der Meer, and E. Briet A method to determine the optimal intensity of oral anticoagulant therapy Thromb Haemost 69 1993 236 239
23. A.J. Rose, D.R. Berlowitz, S.M. Frayne, and E.M. Hylek Measuring quality of oral anticoagulation care: extending quality measurement to a new field Jt Comm J Qual Patient Saf 35 2009 146 155